(Q44494625)

English

Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

V Rickerts

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

J Atta

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

S Herrmann

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

V Jacobi

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

E Lambrecht

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

R Bialek

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

G Just-Nübling

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

49 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

27-30

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Improved outcome of zygomycosis in patients with hematological diseases?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Liposomal Amphotericin B, and Not Amphotericin B Deoxycholate, Improves Survival of Diabetic Mice Infected with Rhizopus oryzae

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

In vitro susceptibilities of zygomycetes to conventional and new antifungals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Activity of posaconazole in treatment of experimental disseminated zygomycosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Posaconazole as salvage therapy for zygomycosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Challenges in designing animal studies to detect antagonism of polyene activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01299.X

21 January 2018

Identifiers

10.1111/J.1439-0507.2006.01299.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44494625&oldid=2025712051"